IL-4 levels are variably reported in PD patients, with some studies indicating no significant differences compared with controls, while others reporting that the population of IL-4-producing cells is significantly lower in PD patients than in controls [187, 199, 211]
Never adjust your semaglutide frequency without consulting your healthcare provider first
Some had been accused of taking the easy way out. I think that there is kind of a stigma that its a cop-out, one participant said, that youre just taking the easy way out rather than doing it with diet and exercise like you should. Reflecting on the findings, de Vere Hunt shares, I expected perceived stigma to be present for people taking GLP-1 RA medications, but I was surprised by how strongly it still emerged in interviews. A particularly important finding, she added, was that many participants felt society viewed GLP-1 use differently depending on the reason: diabetes treatment was seen as legitimate, while obesity treatment was often framed as cheating. Biologically this doesnt make much sense, de Vere Hunt said, as obesity is also a chronic disease involving dysregulated hormonal and metabolic pathways with serious long-term health implications. Yet eligibility criteria, she said, can reinforce the misconception that people do not need medical support to treat obesity alone
Keep a record of the number of clicks to avoid dosing errors
That silence is not a failure of medicine it is an honest description of how individual biology works
